| | | - Compared with industrial mean, the Return comparison fluctuation was low | - Most of related stocks also decline. Medical Supplies industry -1.11% | - Target price KRW 96,600, has 41% disparate to increase compared with stock price. | - Individuals and Foreigners buy, Institutions sell | - Turnover Rate and Price Range both proper | - Institution 17.9%, Foreigners 20.87% |
|
|
As of Oct. 31 09:40 A.M., Daewoong Pharmaceutical (069620) declined 3.13%, compared to 68,100 won (US$59.34). It had declined 21.09% through the past month. Standard deviation, which indicates volatility of stock, records 2.7% over the same period over one month.
Compared with its close competitors within the same industry, KOSPI, evne though the investment return of Daewoong Pharmaceutical was satisfactory among its peer group, its volatility for one month was considerably higher than that of its peer group. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -7.8%. Though the decline rate of stock price is relatively low, the return-on-risk remain high value in spite of high volatility. However, compared with the KOSPI industry, the return-on-risk is below the industrial mean, -4.5, and thus the industrial comparison performance was not so good.
Comparing industry to the market, the KOSPI industry including Daewoong Pharmaceutical records higher volatility but lower earning rate than medical supplies. Even though the earning rate of the industry is negative, the industry was more satisfactory than the market.
Close Competitors | Earning rate (%) | STD (1Mo) | Return on Risk (1Mo) | 1 Mo | 3 Mo | 6 Mo | JW PHARMA(001060) | -45.2% | -8.7% | 28.0% | 3.8% | -11.8 | DAEWOONG PHARMA(069620) | -21.1% | -29.1% | -28.4% | 2.7% | -7.8 | ILYANG PHARM(007570) | -22.1% | -20.5% | -15.0% | 2.6% | -8.4 | CHONGKUNDANG(185750) | -17.2% | -14.9% | -22.9% | 2.4% | -7.1 | DONG-A ST(170900) | -25.2% | -24.9% | -40.6% | 2.3% | -10.9 | | Medical Supplies | -26.6% | -23.9% | -24.5% | 1.8% | -14.7 | KOSPI | -2.7% | -1.2% | -0.6% | 0.6% | -4.5 |
|
Target price 96,600 won, has 41% disparate to increase compared with stock price. Per analysts' expectations during the recent month, the average target price of Daewoong Pharmaceutical is 96,600 won. The stock price is 68,100 won as of yesterday, so there is 28,500 won (41%) disparate in order to be able to increase.
DAEWOONG PHARMA(069620): 2Q(Apr ~ June) of 2016 Earnings (reported at Aug. 17. 2016)
| Revenue | Operating Income | Net Income | 2Q of 2016 | 2,159.5 T | 56.3 T | 49.2 T | Previous Quarter | 2.2% increase | 28.2% increase | 55.0% increase | YoY | 5.8% increase | 65.4% decline | 61.0% decline |
|
Financial structure Overview
Compared with four close competitors with similar market capitalization within its industry, while Daewoong Pharmaceutical's P/E ratio, a price-paid ratio of annual net income, is relatively lower value, its P/B ratio, a financial ratio of a company's book value, records a proper value. |
P/E ratio and P/B ratio
Close Compatitors | ROE | PER | PBR | Basic Date | DAEWOONG PHARMA(069620) | 3.5 | 42.3 | 1.5 | June 2016 | JW PHARMA(001060) | -6.0 | - | 5.1 | June 2016 | ILYANG PHARM(007570) | 5.4 | 69.8 | 3.8 | June 2016 | DONG-A ST(170900) | 5.0 | 29.0 | 1.4 | June 2016 | CHONGKUNDANG(185750) | 8.2 | 33.8 | 2.8 | June 2016 |
Individuals and Foreigners buy, Institutions sell While institutions have been selling Daewoong Pharmaceutical during the past four trading days, foreigners have been buying during the past two trading days. As a shareholding sum by investor group for the past four weeks, foreigners have bought 4,440 shares and individuals have bought 181,559 shares with an increasing position. However, during the same period, institutions have sold 185,999 shares with a selling trend.
Turnover Rate and Price Range both proper Regarding the statistics for the past month on trade volume as the total outstanding shares, the daily turnover rate of Daewoong Pharmaceutical was 0.46%. And the daily volatility, the average range of rise and fall, during the same period is 4.69%.
Institution 17.9%, Foreigners 20.87% As per the inquiry for shareholding by investor group, the major investor group is individuals with 61.22% from total outstanding shares. Foreigners and institutions each hold 20.87% and 17.9%. And as recent five-day shareholding change by investor group, individuals is the major investor group with 57.81%. Institutions hold 21.64% and foreigners hold 20.53%.
Cumulated shareholdings per investor group (1Mo) | | Total shareholdings per investor group | | | |
* Other Investor groups, included as "other corporations", are considered as "Individuals". |
|